<SUBMISSION>
<SECRELEASE-DATETIME> 20070419-100322 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20070419-100322 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20070419-100233 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001192482-07-000184
<TYPE> 4
<PUBLIC-DOCUMENT-COUNT> 1
<PERIOD> 20070417
<FILING-DATE> 20070419
<DATE-OF-FILING-DATE-CHANGE> 20070419
|
<REPORTING-OWNER>
<OWNER-DATA>
<CONFORMED-NAME> DANTZKER DAVID
<CIK> 0001245926
</OWNER-DATA>
<FILING-VALUES>
<FORM-TYPE> 4
<ACT> 34
<FILE-NUMBER> 000-51768
<FILM-NUMBER> 07775069
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 80 CUTTERMILL ROAD STE 311
<CITY> GREAT NECK
<STATE> NY
<ZIP> 11201
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 80 CUTTERMILL ROAD STE 311
<CITY> GREAT NECKK
<STATE> NY
<ZIP> 11201
</MAIL-ADDRESS>
</REPORTING-OWNER>
|
<ISSUER>
<COMPANY-DATA>
<CONFORMED-NAME> Valera Pharmaceuticals Inc
<CIK> 0001305409
<ASSIGNED-SIC> 2834
<IRS-NUMBER> 000000000
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<BUSINESS-ADDRESS>
<STREET1> 8 CLARKE DR
<CITY> CRANBURY
<STATE> NJ
<ZIP> 08512
<PHONE> 609-409-9010
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 8 CLARKE DR
<CITY> CRANBURY
<STATE> NJ
<ZIP> 08512
</MAIL-ADDRESS>
</ISSUER>
|
<DOCUMENT>
<TYPE> 4
<SEQUENCE> 1
<FILENAME> edgar.xml
<DESCRIPTION> PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
Show <XML>: 208 lines (widest: 1,022 characters) - 10K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
